Subsequently, both EGR1 and HNF1A-AS1 inhibit p21 via activation of CDK2 and CDK4, adding another layer of regulatory mechanisms involved in the function of CDK2 in the development of gastric cancer [172]. Here, CDK4 is linked to gastric cancer.